Tellus BioVentures - aVenture Asset Manager Research
Location
Florida, NY, US
Founded
2019
Tellus BioVentures is a biotechnology investment fund dedicated to early-stage innovation and company formation in the life sciences sector. Founded in 2019, the firm focuses on uncovering and accelerating promising biotech innovations, supporting talented entrepreneurs and scientists, and addressing unmet medical needs. Tellus BioVentures typically invests in seed and Series A rounds, with some involvement in Series B and other unspecified rounds.
Notable portfolio companies include Aegle Therapeutics, Interius BioTherapeutics, Navrogen, Praeventix, ViTToria Biotherapeutics, and Zenas BioPharma. The firm is led by key partners who bring extensive experience from various affiliations within the biotech industry. Tellus BioVentures emphasizes a hands-on investment philosophy, providing strategic guidance and operational support to help portfolio companies achieve their growth objectives.
Tellus BioVentures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages